|
1
|
Thomas AA, Brennan CW, DeAngelis LM and
Omuro AM: Emerging therapies for glioblastoma. JAMA Neurol.
71:1437–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Preusser M, de Ribaupierre S, Wöhrer A,
Erridge SC, Hegi M, Weller M and Stupp R: Current concepts and
management of glioblastoma. Ann Neurol. 70:9–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stavrovskaya AA, Shushanov SS and
Rybalkina EY: Problems of glioblastoma multiforme drug resistance.
Biochemistry (Mosc). 81:91–100. 2016. View Article : Google Scholar
|
|
4
|
Sarkaria JN, Kitange GJ, James CD, Plummer
R, Calvert H, Weller M and Wick W: Mechanisms of chemoresistance to
alkylating agents in malignant glioma. Clin Cancer Res.
14:2900–2908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xue M, Chen W and Li X: Urothelial cancer
associated 1: A long noncoding RNA with a crucial role in cancer. J
Cancer Res Clin Oncol. 142:1407–1419. 2016. View Article : Google Scholar
|
|
7
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P,
Yuan Z, Deng Y, Wang J, Chen D, et al: Increased urothelial cancer
associated 1 is associated with tumor proliferation and metastasis
and predicts poor prognosis in colorectal cancer. Int J Oncol.
47:1329–1338. 2015.PubMed/NCBI
|
|
9
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016.PubMed/NCBI
|
|
10
|
Sun QL, Zhao CP, Wang TY, Hao XB, Wang XY,
Zhang X and Li YC: Expression profile analysis of long non-coding
RNA associated with vincristine resistance in colon cancer cells by
next-generation sequencing. Gene. 572:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parasramka MA, Maji S, Matsuda A, Yan IK
and Patel T: Long non-coding RNAs as novel targets for therapy in
hepatocellular carcinoma. Pharmacol Ther. 161:67–78. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He DX, Zhang GY, Gu XT, Mao AQ, Lu CX, Jin
J, Liu DQ and Ma X: Genome-wide profiling of long non-coding RNA
expression patterns in anthracycline-resistant breast cancer cells.
Int J Oncol. 49:1695–1703. 2016.PubMed/NCBI
|
|
13
|
Pan J, Li X, Wu W, Xue M, Hou H, Zhai W
and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine
resistance through CREB modulating miR-196a-5p in bladder cancer
cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li W, Zhai L, Wang H, Liu C, Zhang J, Chen
W and Wei Q: Downregulation of LncRNA GAS5 causes trastuzumab
resistance in breast cancer. Oncotarget. 7:27778–27786.
2016.PubMed/NCBI
|
|
15
|
Munoz JL, Rodriguez-Cruz V, Greco SJ,
Ramkissoon SH, Ligon KL and Rameshwar P: Temozolomide resistance in
glioblastoma cells occurs partly through epidermal growth factor
receptor-mediated induction of connexin 43. Cell Death Dis.
5:e11452014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Munoz JL, Rodriguez-Cruz V, Greco SJ,
Nagula V, Scotto KW and Rameshwar P: Temozolomide induces the
production of epidermal growth factor to regulate MDR1 expression
in glioblastoma cells. Mol Cancer Ther. 13:2399–2411. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Munoz JL, Walker ND, Scotto KW and
Rameshwar P: Temozolomide competes for P-glycoprotein and
contributes to chemoresistance in glioblastoma cells. Cancer Lett.
367:69–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Guil S and Esteller M: RNA-RNA
interactions in gene regulation: The coding and noncoding players.
Trends Biochem Sci. 40:248–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan Y, Zhang L, Jiang Y, Xu T, Mei Q, Wang
H, Qin R, Zou Y, Hu G, Chen J, et al: LncRNA and mRNA interaction
study based on transcriptome profiles reveals potential core genes
in the pathogenesis of human glioblastoma multiforme. J Cancer Res
Clin Oncol. 141:827–838. 2015. View Article : Google Scholar
|
|
21
|
Cao G, Zhang J, Wang M, Song X, Liu W, Mao
C and Lv C: Differential expression of long non-coding RNAs in
bleomycin-induced lung fibrosis. Int J Mol Med. 32:355–364.
2013.PubMed/NCBI
|
|
22
|
Fan CH, Liu WL, Cao H, Wen C, Chen L and
Jiang G: O6-methylguanine DNA methyltransferase as a
promising target for the treatment of temozolomide-resistant
gliomas. Cell Death Dis. 4:e8762013. View Article : Google Scholar
|
|
23
|
Hartmann C, Hentschel B, Simon M, Westphal
M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von
Deimling A, et al: German Glioma Network: Long-term survival in
primary glioblastoma with versus without isocitrate dehydrogenase
mutations. Clin Cancer Res. 19:5146–5157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schaich M, Kestel L, Pfirrmann M, Robel K,
Illmer T, Kramer M, Dill C, Ehninger G, Schackert G and Krex D: A
MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome
of temozolomide treatment in glioblastoma patients. Ann Oncol.
20:175–181. 2009. View Article : Google Scholar
|
|
25
|
Lin F, de Gooijer MC, Roig EM, Buil LC,
Christner SM, Beumer JH, Würdinger T, Beijnen JH and van Tellingen
O: ABCB1, ABCG2, and PTEN determine the response of glioblastoma to
temozolomide and ABT-888 therapy. Clin Cancer Res. 20:2703–2713.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang YY, Zhang T, Li SW, Qian TY, Fan X,
Peng XX, Ma J, Wang L and Jiang T: Mapping p53 mutations in
low-grade glioma: A voxel-based neuroimaging analysis. AJNR Am J
Neuroradiol. 36:70–76. 2015. View Article : Google Scholar
|
|
27
|
Turner KM, Sun Y, Ji P, Granberg KJ,
Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, et al:
Genomically amplified Akt3 activates DNA repair pathway and
promotes glioma progression. Proc Natl Acad Sci USA. 112:3421–3426.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trivedi RN, Almeida KH, Fornsaglio JL,
Schamus S and Sobol RW: The role of base excision repair in the
sensitivity and resistance to temozolomide-mediated cell death.
Cancer Res. 65:6394–6400. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li
CH and Leung GK: MicroRNA-21 inhibition enhances in vitro
chemosensitivity of temozolomide-resistant glioblastoma cells.
Anticancer Res. 32:2835–2841. 2012.PubMed/NCBI
|
|
30
|
Ujifuku K, Mitsutake N, Takakura S,
Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K,
Nagata I, et al: miR-195, miR-455-3p and miR-10a(*) are implicated
in acquired temozolomide resistance in glioblastoma multiforme
cells. Cancer Lett. 296:241–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsang WP, Wong TW, Cheung AH, Co CN and
Kwok TT: Induction of drug resistance and transformation in human
cancer cells by the noncoding RNA CUDR. RNA. 13:890–898. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng N, Li X, Zhao C, Ren S, Chen X, Cai
W, Zhao M, Zhang Y, Li J, Wang Q, et al: Microarray expression
profile of long non-coding RNAs in EGFR-TKIs resistance of human
non-small cell lung cancer. Oncol Rep. 33:833–839. 2015.
|
|
35
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Bian EB, He XJ, Ma CC, Zong G, Wang
HL and Zhao B: Epigenetic repression of long non-coding RNA MEG3
mediated by DNMT1 represses the p53 pathway in gliomas. Int J
Oncol. 48:723–733. 2016.
|
|
37
|
Zhang J, Zhang P, Wang L, Piao HL and Ma
L: Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
Acta Biochim Biophys Sin (Shanghai). 46:1–5. 2014. View Article : Google Scholar
|
|
38
|
Xia H and Hui KM: Mechanism of cancer drug
resistance and the involvement of noncoding RNAs. Curr Med Chem.
21:3029–3041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Idbaih A, Carvalho Silva R, Crinière E,
Marie Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A,
Mokhtari K, Ducray F, et al: Genomic changes in progression of
low-grade gliomas. J Neurooncol. 90:133–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Geng P, Ou J, Li J, Liao Y, Wang N, Xie G,
Sa R, Liu C, Xiang L and Liang H: A comprehensive analysis of
influence ERCC polymorphisms confer on the development of brain
tumors. Mol Neurobiol. 53:2705–2714. 2016. View Article : Google Scholar
|
|
41
|
Pasqualato A, Palombo A, Cucina A,
Mariggiò MA, Galli L, Passaro D, Dinicola S, Proietti S, D'Anselmi
F, Coluccia P, et al: Quantitative shape analysis of chemoresistant
colon cancer cells: Correlation between morphotype and phenotype.
Exp Cell Res. 318:835–846. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Uppal SO, Li Y, Wendt E, Cayer ML, Barnes
J, Conway D, Boudreau N and Heckman CA: Pattern analysis of
microtubule-polymerizing and -depolymerizing agent combinations as
cancer chemotherapies. Int J Oncol. 31:1281–1291. 2007.PubMed/NCBI
|
|
43
|
Chetty C, Vanamala SK, Gondi CS, Dinh DH,
Gujrati M and Rao JS: MMP-9 induces CD44 cleavage and CD44 mediated
cell migration in glioblastoma xenograft cells. Cell Signal.
24:549–559. 2012. View Article : Google Scholar :
|
|
44
|
Guadagno E, Borrelli G, Califano M, Calì
G, Solari D and Del Basso De Caro M: Immunohistochemical expression
of stem cell markers CD44 and nestin in glioblastomas: Evaluation
of their prognostic significance. Pathol Res Pract. 212:825–832.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pinel B, Duchesne M, Godet J, Milin S,
Berger A, Wager M and Karayan-Tapon L: Mesenchymal subtype of
glioblastomas with high DNA-PKcs expression is associated with
better response to radiotherapy and temozolomide. J Neurooncol.
132:287–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
